Drugs / Infanrix+Hib
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01323647 Background | Apr → Sep 2011 | poliomyelitis | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Infanrix+Hib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01323647 ↗ |
| Modality | Vaccine | “DTPa/Hib vaccine” NCT01323647 ↗ |